Class action lawsuits filed against Gossamer Bio, New Era Energy, and Medpace Holdings for misleading investors.

Class action lawsuits have been filed against Gossamer Bio, New Era Energy, and Medpace Holdings, accusing them of making false or misleading statements and failing to disclose adverse facts about their businesses. The lawsuits claim these companies misrepresented clinical trial results, regulatory progress, and financial projections, leading to investor losses. Deadlines for investors to file lead plaintiff motions are in early June 2026. Affected shareholders are encouraged to contact legal counsel to explore their rights and potential claims.